Bisaro Paul 4
4 · Keenova Therapeutics plc · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Bisaro Paul
Director
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-02-23+3,984→ 47,225 total→ Ordinary Shares (3,984 underlying)
Footnotes (2)
- [F1]Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU.
- [F2]Each RSU will fully vest on February 23, 2027.
Signature
/s/ Mark Tyndall, Attorney-in-Fact|2026-02-25